Tina Benny

Tina Benny

Auto-generated profile, based on publicly available information

Tina Benny

Nova Southeastern University College of Pharmacy Davie Florida USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2020 in Journal of Pharmacy Practice
Verified
Journal Article
Closed access
PDF file
TJTina Joseph
Tina Joseph
GHGenevieve Marie Hale
Genevieve Marie Hale
CMCynthia Moreau
Cynthia Moreau
ERElaina D. Rosario
Elaina D. Rosario
NLNichelle Logan
Nichelle Logan
APAlexandra Perez
Alexandra Perez
Background: The Centers for Medicare and Medicaid Services (CMS) publishes quality measures to gauge performance in Accountable Care Organizations (ACOs). ACO-27 (Diabetes Mellitus: Hemoglobin A1c Poor Control) and ACO-41 (Diabetes: Eye Exam), are 2 components for the Diabetes Composite measure. ACO-42 focuses on Statin Therapy for the Prevention and Treatment of Cardiovascular (CV) Disease. There are limited studies regarding the pharmacist role in CV and Diabetes Management in the ACO primary care setting. Objective: To evaluate the impact of pharmacist-led interventions on CV- and diabetes-related CMS quality measures within a primary care-based ACO. Methods: This retrospective pre-post intervention study included 3 primary care-based ACO offices. Patients who met eligibility criteria for CMS quality measures ACO-27, -41 and -42 were included. Pharmacist interventions occurred in December 2018. The study co-primary outcomes were the percentage of patient meeting ACO-27/-41 (composite diabetes-related) and -42 (statin-related) CMS quality measures in the pre-intervention compared to the post-intervention phases. Results: Of 105 patients meeting study inclusion criteria, 77.1% were on statin therapy prior to intervention. After pharmacist intervention, the prevalence of patients on statin therapy increased to 80.0% (p = 0.083). All patients had a HbA1c less than 9% pre-intervention. Sixty-one (58.1%) patients had a documented dilated eye exam prior to intervention. Post-intervention, the prevalence of exams increased to 73.3% (p < 0.0005). Conclusions: Pharmacists can assist primary care providers in the ACO setting meet CV- and diabetes-related CMS quality measures, demonstrating the value of the pharmacist in value-based health care settings.

1 September 2018 in Journal of Interprofessional Education & Practice
Verified
Journal Article
Closed access
GHGenevieve M. Hale
Genevieve M. Hale
TJTina Joseph
Tina Joseph
SMStacey Maravent
Stacey Maravent
DSDebra Stern
Debra Stern
SASarah Alameddine
Sarah Alameddine
APAlexandra Perez
Alexandra Perez

5 April 2024 in JAPhA Practice Innovations
Verified
Journal Article
Open access
TBTina Benny
Tina Benny
MLMarija Lapkus
Marija Lapkus
GHGenevieve Marie Hale
Genevieve Marie Hale
CMCynthia Moreau
Cynthia Moreau
APAlexandra Perez
Alexandra Perez
EZErika Zwachte
Erika Zwachte

25 August 2025 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
.B.Andrea Bush
.Andrea Bush
TBTina Benny
Tina Benny
GHGenevieve Marie Hale
Genevieve Marie Hale
MSMatthew Seamon
Matthew Seamon
MCMekaliah Creese
Mekaliah Creese